Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPrognostic significance of a pretreatment hematologic profile in patients with head and neck cancer
Journal of Cancer Research & Clinical Oncology, 06/30/09
Chen MH et al. - In a study to test whether the pretreatment hematologic profile can predict prognosis of pts with head and neck cancer (HNC), it was shown that a pretreatment hematologic profile can be considered as a useful prognostic marker in pts with HNC.
Methods- Medical records from 278 pts with HNC were reviewed, and 270 cases were evaluable.
- Clinical data including age, gender, stage, pretreatment hematologic profile (including white blood cell, platelet, and differential counts, and hemoglobin level) were recorded.
- Statistical analyses were performed to determine the prognostic effect of these hematologic indicators, as well as clinical variables.
- Association between hematologic indicators and clinical factors was also analyzed.
- Pretreatment monocytes >1000 cells/μl, hemoglobin <11.0 g/dl, and platelet count >400 x 103 cells/μl were identified as independent prognostic factors in addition to nodal status and metastasis.
- A significant correlation between T-stage/monocyte or platelet count and metastasis/platelet count were shown.
- Monocytosis, anemia, and thrombocytosis were demonstrated to have a cumulative effect on prognosis of HNC pts (normal vs abnormality in 1 lineage; abnormality in 1 vs >1 lineage).
Related Articles
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 84%
Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 83%
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 83%
Clinical Features and Short-Term Outcome of Critically Ill Patients With Head and Neck Cancer in the Medical Intensive Care Unit
American Journal of Clinical Oncology, 10/07/09
Relevance Score: 83%
Sheddase Activity of Tumor Necrosis Factor-alpha Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 82%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
British Journal of Cancer, 12/10/09
Human papillomavirus infection and squamous cell carcinoma of the conjunctiva
British Journal of Cancer, 12/10/09
Effects of functional electrical stimulation on dysphagia caused by radiation therapy in patients with nasopharyngeal carcinoma
Supportive Care in Cancer, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor